What is DPX Technologies?
DPX Technologies operates at the intersection of analytical chemistry and laboratory automation, specializing in the development of INTip solutions for solid phase extraction and filtration. The company's core value proposition lies in its versatile pipette tip designs, which are engineered to integrate seamlessly into existing laboratory workflows, thereby reducing manual intervention and minimizing plastic waste. By addressing the critical bottleneck of sample preparation, DPX Technologies serves a diverse clientele spanning the cannabis, food safety, proteomics, and clinical diagnostics industries. Their commitment to enhancing efficiency through modular, automated hardware positions them as a vital infrastructure provider in the modern scientific research ecosystem.
How much funding has DPX Technologies raised?
DPX Technologies has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in DPX Technologies
PPP
Public-Private Partnership
What's next for DPX Technologies?
With the successful closure of this $150K financing, DPX Technologies is expected to prioritize the expansion of its manufacturing capabilities and the diversification of its product portfolio. The strategic roadmap likely includes deepening its footprint in the genomics and proteomics sectors, where the demand for high-precision, automated sample preparation is accelerating. Furthermore, the company is well-positioned to invest in R&D initiatives aimed at further reducing the environmental impact of laboratory consumables, a key differentiator in today's sustainability-conscious market. As the firm transitions into this next phase of growth, the focus will remain on scaling operations to support global laboratory adoption while maintaining the technical rigor that has defined its market presence to date.
See full DPX Technologies company page
